News

NORTHAMPTON, MA / ACCESS Newswire / June 10, 2025 / Teva Pharmaceuticals has been recognized with the 2025 Power of ...
Chicago, IL – June 10, 2025 – Today, Zacks Equity Research discusses Sandoz SDZNY, Teva Pharmaceuticals TEVA and Viatris VTRS ...
Patent lawyers are racing to adapt how they draft and defend drug-device patents after a court ruling reshaped the FDA’s ...
NORTHAMPTON, MA / ACCESS Newswire / June 10, 2025 / Teva Pharmaceuticals has been recognized with the 2025 Power of Partnership Award by Americares, in collaboration with the Healthcare Distribution A ...
Teva Pharmaceutical (TEVA) stock, Amneal Pharma (AMRX) stock receive Buy ratings and Viatris (VTRS) stock receives a Neutral rating at Goldman Sachs. Read more here.
Goldman Sachs initiated coverage on U.S.-listed generic pharmaceutical companies with Buy ratings on Teva Pharmaceutical Industries (NYSE:TEVA) and Amneal Pharmaceuticals (NASDAQ:AMRX), and a Neutral ...
All SDRs and shares allocated have now been delivered to the counterparties, with a transfer of 7.5 million treasury shares ...
Here are seven new shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. Editor’s note: The drugs listed are in alphabe ...
Fintel reports that on June 6, 2025, Goldman Sachs initiated coverage of Teva Pharmaceutical Industries Limited - Depositary ...
TEVA) and Amneal Pharmaceuticals (NASDAQ:AMRX), and a Neutral rating on Viatris, citing improving fundamentals, strong free cash flow, and undemanding valuations. TEL AVIV, Israel, June 03, 2025 ...
"Under the circumstances—including the lack of evidence regarding harm that Nike will suffer, the brevity of the stay, and ...
The benefits of 52-week biologic therapy on asthma control and lung function are observed in both never smokers and ...